AI Matters
Why it matters
OpenAI acquires biotech startup Orchestra Bio
TechCrunch OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI is acquiring Orchestra Bio and adding its team and technology to its Rosalind life sciences model and Rosalind Workbench research tool.
Why it matters
Signals OpenAI is pushing AI further into drug research, which could speed up how new treatments are developed.
Latest brief · Oct 21, 2026